Mentice and Siemens Healthineers Collaborate on Simulation System in the Angiosuite

 

June 24, 2019—Siemens Healthineers and Mentice AB announced a collaboration to fully integrate Mentice’s Vascular Interventional System Trainer (VIST) virtual patient into Siemens' Artis icono angiography system, making the VIST virtual patient a fully integrated simulation solution for the angiosuite. The global partnership between the two companies will allow interventional radiologists, neuroradiologists, and cardiologists to perform vascular and cardiac interventions on a virtual patient inside the angiosuite.

By integrating the VIST system with the Artis icono system, interventionalists may perform simulated cardiac and vascular procedures by using the Artis icono controls to angulate the C-arm, move the angiography table, use the foot pedals, and review fluoroscopic images on the Artis icono screens while deploying actual medical devices in a radiation-free environment.

Additionally, clinicians can perform procedures either by using Mentice’s library of patient cases or importing actual patient data from MRI and CT for case training and rehearsal. Transesophageal echocardiography, intravascular ultrasound, optical coherence tomography, and fractional flow reserve procedures are also available.

The companies advised that Siemens' Artis icono and its features are pending FDA 510(k) clearance and are not yet commercially available in the United States. Additionally, the system is not commercially available in all countries. The VIST virtual patient, VIST simulators, and VIST acquisition software are currently commercially available through Mentice globally.

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.